Reported about 6 hours ago
WeightWatchers' stock price is on the rise following the announcement of their new compounded GLP-1 weight-loss medication, priced starting at $129, which aims to provide an accessible solution for weight management. The medication positions the company to compete against established GLP-1 drugs such as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro.
Source: YAHOO